Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 2
2019 14
2020 200
2021 203
2022 203
2023 148
2024 145
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

789 results

Results by year

Filters applied: . Clear all
Page 1
Opioids and Opioid Use Disorder in Pregnancy.
Sanjanwala AR, Lim G, Krans EE. Sanjanwala AR, et al. Obstet Gynecol Clin North Am. 2023 Mar;50(1):229-240. doi: 10.1016/j.ogc.2022.10.015. Obstet Gynecol Clin North Am. 2023. PMID: 36822706 Review.
As such, all obstetric providers have a responsibility to provide evidence-based care for patients with opioid use disorder to mitigate adverse outcomes associated with substance use during pregnancy....
As such, all obstetric providers have a responsibility to provide evidence-based care for patients with opioid use disorder to mitiga …
The changing opioid crisis: development, challenges and opportunities.
Volkow ND, Blanco C. Volkow ND, et al. Mol Psychiatry. 2021 Jan;26(1):218-233. doi: 10.1038/s41380-020-0661-4. Epub 2020 Feb 4. Mol Psychiatry. 2021. PMID: 32020048 Free PMC article. Review.
This review examines the origin and evolution of the crisis, the pharmacological properties of opioids, the neurobiology of opioid use and opioid use disorder (OUD), medications for opioid use disorder (MOUD), and existing and promising approaches to p …
This review examines the origin and evolution of the crisis, the pharmacological properties of opioids, the neurobiology of opioid …
Low-Dose Naltrexone for Chronic Pain: Update and Systemic Review.
Kim PS, Fishman MA. Kim PS, et al. Curr Pain Headache Rep. 2020 Aug 26;24(10):64. doi: 10.1007/s11916-020-00898-0. Curr Pain Headache Rep. 2020. PMID: 32845365
PURPOSE OF REVIEW: The purpose of this review is to evaluate and explain our current understanding of the clinical use of low-dose naltrexone in the treatment of chronic pain. RECENT FINDINGS: Recent pre-clinical uses and clinical studies further eluci …
PURPOSE OF REVIEW: The purpose of this review is to evaluate and explain our current understanding of the clinical use of low-dose na …
New directions in the treatment of opioid withdrawal.
Srivastava AB, Mariani JJ, Levin FR. Srivastava AB, et al. Lancet. 2020 Jun 20;395(10241):1938-1948. doi: 10.1016/S0140-6736(20)30852-7. Lancet. 2020. PMID: 32563380 Free PMC article. Review.
The treatment of opioid withdrawal is an important area of clinical concern when treating patients with chronic, non-cancer pain, patients with active opioid use disorder, and patients receiving medication for opioid use disorder. ...Newer agent …
The treatment of opioid withdrawal is an important area of clinical concern when treating patients with chronic, non-ca …
Treatment of opioid overdose: current approaches and recent advances.
Britch SC, Walsh SL. Britch SC, et al. Psychopharmacology (Berl). 2022 Jul;239(7):2063-2081. doi: 10.1007/s00213-022-06125-5. Epub 2022 Apr 7. Psychopharmacology (Berl). 2022. PMID: 35385972 Free PMC article. Review.
Naloxone is the primary opioid overdose reversal agent, but concern has been raised that naloxone is not efficacious against the pervasive illicit high potency opioids (i.e., fentanyl and fentanyl analogs). ...No well-controlled studies have been condu …
Naloxone is the primary opioid overdose reversal agent, but concern has been raised that naloxone is not efficacious against the perv …
Clinical Management of Opioid Withdrawal.
Torres-Lockhart KE, Lu TY, Weimer MB, Stein MR, Cunningham CO. Torres-Lockhart KE, et al. Addiction. 2022 Sep;117(9):2540-2550. doi: 10.1111/add.15818. Epub 2022 Feb 22. Addiction. 2022. PMID: 35112746 Review.
Appropriate clinical management of opioid withdrawal is a crucial bridge to long-term treatment for opioid use disorder (OUD), because it is a high-risk time for potential opioid overdose and relapse. We provide a narrative review of evidence-ba …
Appropriate clinical management of opioid withdrawal is a crucial bridge to long-term treatment for opioid use d …
Understanding and countering opioid-induced respiratory depression.
Bateman JT, Saunders SE, Levitt ES. Bateman JT, et al. Br J Pharmacol. 2023 Apr;180(7):813-828. doi: 10.1111/bph.15580. Epub 2021 Jun 26. Br J Pharmacol. 2023. PMID: 34089181 Free PMC article. Review.
The goal of this review is to provide a comprehensive understanding of the pharmacological mechanisms of opioid-induced respiratory depression, which could lead to improved therapeutic options to counter opioid overdose, as well as other detrimental effects of op …
The goal of this review is to provide a comprehensive understanding of the pharmacological mechanisms of opioid-induced respiratory d …
Opioid Overdose: Limitations in Naloxone Reversal of Respiratory Depression and Prevention of Cardiac Arrest.
van Lemmen M, Florian J, Li Z, van Velzen M, van Dorp E, Niesters M, Sarton E, Olofsen E, van der Schrier R, Strauss DG, Dahan A. van Lemmen M, et al. Anesthesiology. 2023 Sep 1;139(3):342-353. doi: 10.1097/ALN.0000000000004622. Anesthesiology. 2023. PMID: 37402248 Review.
Naloxone is currently the only available treatment for reversing the negative effects of opioids, including respiratory depression. ...Long-acting opioids, and those with a high affinity at the -opioid receptor and/or slow receptor dissociation kinetic …
Naloxone is currently the only available treatment for reversing the negative effects of opioids, including respiratory depres …
Oxycodone in the Opioid Epidemic: High 'Liking', 'Wanting', and Abuse Liability.
Kibaly C, Alderete JA, Liu SH, Nasef HS, Law PY, Evans CJ, Cahill CM. Kibaly C, et al. Cell Mol Neurobiol. 2021 Jul;41(5):899-926. doi: 10.1007/s10571-020-01013-y. Epub 2020 Nov 27. Cell Mol Neurobiol. 2021. PMID: 33245509 Free PMC article. Review.
It is estimated that nearly a third of people who abuse drugs started with prescription opioid medicines. Approximately, 11.5 million Americans used prescription drugs recreationally in 2016, and in 2018, 46,802 Americans died as the result of an opioid overdose, in …
It is estimated that nearly a third of people who abuse drugs started with prescription opioid medicines. Approximately, 11.5 million …
Diagnosis and Management of Opioid Use Disorder in Hospitalized Patients.
Herscher M, Fine M, Navalurkar R, Hirt L, Wang L. Herscher M, et al. Med Clin North Am. 2020 Jul;104(4):695-708. doi: 10.1016/j.mcna.2020.03.003. Epub 2020 May 12. Med Clin North Am. 2020. PMID: 32505261 Review.
The diagnosis of opioid use disorder (OUD) is often overlooked or inadequately managed during the inpatient admission. ...Medication for addiction treatment (MAT), including methadone and buprenorphine, is effective and can be dispensed in the hospital for bo …
The diagnosis of opioid use disorder (OUD) is often overlooked or inadequately managed during the inpatient admission. ...Medication …
789 results